Menopausal Hot Flashes Market Growth, Share, Size, Overview Report, Forecast 2028

Menopausal Hot Flashes Market

Global Menopausal Hot Flashes Market By Treatment Type (Hormonal Treatment, Non-hormonal Treatment, and Alternative Treatment), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Category: Healthcare Report Format : PDF Pages: 265 Report Code: ZMR-6180 Published Date: Aug-2022 Status : Published

The global menopausal hot flashes market size was worth USD 31,926.50 Million in 2021 and is estimated to grow to USD 42,297.91 Million by 2028, with a compound annual growth rate (CAGR) of approximately 4.80% From 2022-2028.

Menopausal Hot Flashes Market Size And Industry Analysis

The global menopausal hot flashes market size was worth USD 31,926.50 million in 2021 and is estimated to grow to USD 42,297.91 million by 2028, with a compound annual growth rate (CAGR) of approximately 4.80 percent over the forecast period. The report analyzes the menopausal hot flashes market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the menopausal hot flashes market.

Menopausal Hot Flashes Market: Overview

Menopause is patent by hot flashes, which are the furthermost common. Hot flashes are thought to result from changes in the hypothalamus, the part of the brain that regulates body temperature; However, the exact reason is still unknown. The rise of postmenopausal symptoms due to the shift to a sedentary lifestyle is expected to drive the market. The increasing incidence of vasomotor and menopausal symptoms such as night sweats and hot flashes among women during the menopausal transition is expected to drive market growth. In addition, problems such as mood swings, difficulty concentrating, and depression are associated with menopause. In addition, increased investment in treating menopausal manifestations is expected to boost the market.

Global Menopausal Hot Flashes Market SizeRequest Free Sample

COVID-19 Impact:

The COVID-19 pandemic has impacted the businesses of menopausal hot flashes. The COVID-19 pandemic spread throughout the world as strict lock-downs are implemented by governments and shut down companies. Thus, the movement of people is restricted during the Covid-19 pandemic; the global menopausal hot flashes market is likely to be impacted considerably during the forecast period.

Key Insights

  • As per the analysis shared by our research analyst, the global menopausal hot flashes market value is expected to grow at a CAGR of 4.80% over the forecast period.
  • In terms of revenue, the global menopausal hot flashes market size was valued at USD 31,926.50 million in 2021 and is estimated to grow to USD 42,297.91 million by 2028.
  • The rise of postmenopausal symptoms due to the shift to a sedentary lifestyle is expected to drive the market.
  • By treatment type, the hormonal treatment segment dominated with accounted significant market share in 2021.
  • By distribution channel, the hospital pharmacies segment accounted significant amount of market share in 2021.
  • In 2021, North America captured the largest revenue share of the global market.

Global Menopausal Hot Flashes Market: Report Scope:

Report Attributes Report Details
Report Name Menopausal Hot Flashes Market
Market Size in 2021 USD 31,926.50 Million
Market Forecast in 2028 USD 42,297.91 Million
Compound Annual Growth Rate CAGR of 4.80%
Number of Pages 265
Forecast Units Value (USD Million), and Volume (Units)
Key Companies Covered Pfizer Inc., Novartis AG, Novo Nordisk A/S, Allergan plc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., GlaxoSmithKline plc, TherapeuticsMD Inc.
Segments Covered By Treatment, By Distribution Channel And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latian America, Middle East and Africa (MEA)
Countries Covered North America: U.S and Canada
Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Chile
The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2021
Historical Year 2016 to 2020
Forecast Year 2021 - 2028
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization


To know more about this report, request a sample copy.

Menopausal Hot Flashes Market: Growth Drivers

The increasing prevalence of menopausal hot flashes aids the global market growth

The main driving factors of the global menopausal hot flashes market are the increasing prevalence of menopausal hot flashes, the growing number of new pharmacological approvals for the treatment, and increasing health awareness. Hot flashes are a rapid feeling of heat that mainly affects the chest, neck, and face. Some key variables driving the strong growth of the menopausal hot flashes market are the frequency of fluctuations in high estrogen levels and impaired musculoskeletal health in women. As a result, healthcare companies are stepping up clinical studies of hormone-free products to meet various needs.

Menopausal Hot Flashes Market: Restraints

The side effects related to menopausal hot flashes may hamper the global market growth

The key restraints for the menopausal hot flashes market are the side effects of menopausal hot flashes, such as vaginal bleeding, hip & vertebral fractures, dementia, urinary incontinence, breast cancer, heart attack, blood clots, stroke, colon cancer rectal. Because of these side effects, patients seek safer treatments such as herbal products and supplements, major restraint that is expected to impede the growth of the global menopausal hot flashes market during the forecast period.

Menopausal Hot Flashes Market: Opportunities

The advancements by market players bring up several growth opportunities

Companies in the global menopausal hot flashes market recommend lifestyle changes for women through online media. Likewise, companies are developing innovative devices tailored to the needs of women. For example, the introduction of Monopod has fueled the growth of the menopause flash market due to its compact mouse-like shape and portability. The advent of smartwatch-type devices that act as personal thermostats for women is also driving the global market.

Menopausal hot flashes Market: Segmentation

The global menopausal hot flashes market is segregated based on treatment type, distribution channel, and region.

By treatment type, the market is divided into hormonal treatment, non-hormonal treatment, and alternative treatment. Among these, in 2021, the hormonal treatment segment dominated the market, accounting for a significant percentage of global sales due to the increasing demand for menopausal hot flashes treatment. Also, it will grow with the highest CAGR during the forecast period.

By distribution channel, the market is categorized into retail pharmacies, hospital pharmacies, and online pharmacies. Over the forecast period, the hospital pharmacies segment is expected to develop at the fastest rate due to the increased checkups in hospitals.

Recent Developments

  • December 2021 - Acer Therapeutics Inc. was approved by the U.S. Food and Drug Administration (FDA) for the registration of Investigative New Drugs (IND) for the selective neurokinin 3 (NK3R) non-peptide receptor antagonist, ACER-801 (osanetant) for the potential treatment of Induced Vasomotor Symptoms (iVMS).
  • February 2021 - Astella Pharma Inc. published positive results from the pivotal phase 3 clinical trials of SKYLIGHT 1 and SKYLIGHT 2 or fezolintant, a non-hormonal oral compound being studied for the treatment of central vasomotor symptoms. Moderate to severe (VMS) (hot flashes associated with menopause).

Menopausal Hot Flashes Market: Regional Landscape

The growing population of geriatric women helps North America dominates the global market

North America is leading the global menopausal hot flashes market due to the growing population of geriatric women with menopausal symptoms in the United States and Canada. This industry is expected to grow to meet the increasing demand for medical treatments during hot flashes. According to the National Center for Biotechnology Information (NCBI), about 85% of postmenopausal women have experienced symptoms related to menopause (hot flashes). According to the North American Menopause Society, about 75% of North American women experience hot flashes during perimenopause. Nearly a quarter of them are so bothered that they need to see a doctor. Menopause is common among older women, increasing the market's overall growth rate. In addition, technical improvements in the production of new pharmaceuticals, increased spending on healthcare and the presence of a well-established healthcare infrastructure all contribute to the market's growth.

Menopausal Hot Flashes Market: Competitive Landscape

Some of the main competitors dominating the global menopausal hot flashes market include - Pfizer Inc., Novartis AG, Novo Nordisk A/S, Allergan plc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., GlaxoSmithKline plc, TherapeuticsMD Inc.

Global Menopausal Hot Flashes Market shareRequest Free Sample

The global menopausal hot flashes market is segmented as follows:

By Treatment Type

  • Hormonal Treatment
  • Non-hormonal Treatment
  • Alternative Treatment

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

The main driving factors of the menopausal hot flashes market are the increasing prevalence of menopausal hot flashes, the growing number of new pharmacological approvals for the treatment, and increasing health awareness. Hot flashes are a rapid feeling of heat that mainly affects the chest, neck, and face. Hot flashes are an immediate feeling of warmth that affects the chest, neck, and face. Some key variables driving the strong growth of the menopausal hot flashes market are the frequency of fluctuations in high estrogen levels and impaired musculoskeletal health in women. As a result, healthcare companies are stepping up clinical studies of hormone-free products to meet various needs.

According to a report, the global menopausal hot flashes market was worth 31,926.50 (USD million) in 2021 and is predicted to grow to 42,297.91 (USD Million) by 2028, with a compound annual growth rate (CAGR) of about 4.80 percent.

North America is leading the menopausal hot flashes market due to the growing population of geriatric women with menopausal symptoms in the United States and Canada. This industry is expected to grow to meet the increasing demand for medical treatments during hot flashes. In addition, technical improvements in the production of new pharmaceuticals, increased spending on healthcare and the presence of a well-established healthcare infrastructure all contribute to the market's growth.

Some of the main competitors dominating the global menopausal hot flashes market include Pfizer Inc., Novartis AG, Novo Nordisk A/S, Allergan plc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., GlaxoSmithKline plc, TherapeuticsMD Inc.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed